By Kevin Connolly 
July 20, 2017 A government alert slowed inferior vena cava implants in 2010 but the U.S. still uses far more of the controversial clot-blocking devices than European countries, a new study found. The rate of inferior vena cava (IVC) filter placements in this country dropped 29...
By Kevin Connolly 
July 14, 2017 Two former sales representatives for an Arizona-based drug company pled guilty this week to participating in a multimillion-dollar kickback scheme designed to boost sales of a powerful prescription painkiller, federal officials announced. The now-defunct program at...
By Elaine Silvestrini 
July 6, 2017 A month after the U.S. Food and Drug Administration’s unprecedented request that a painkiller be taken off the market because of issues with abuse, Endo International has agreed to voluntarily stop selling Opana ER and recall the drug from the U.S. market. The...
By Elaine Silvestrini 
A Philadelphia jury has awarded a $20 million verdict in favor of a New Jersey woman who suffered complications after a June 2007 pelvic-mesh procedure. The award — $17.5 million of which was for punitive damages — is the latest against Ethicon, a subsidiary...
By Kristin Compton 
A federal jury in New Orleans recently sided with drugmakers Bayer AG and Johnson & Johnson in the first bellwether trial from plaintiffs alleging they were harmed by the blood-thinning drug Xarelto. Joseph Boudreaux, 75, of Louisiana blamed the drugmakers for...
By Michelle Llamas 
The first Xarelto bellwether trial began on April 24, 2017 in New Orleans, and the plaintiff accused Johnson & Johnson and Bayer of failing to warn that the blood thinner could cause serious or fatal bleeding. Joseph Boudreaux took Xarelto to help cut his stroke risk,...
By Michelle Llamas 
An additional 3,000 plaintiffs filed Risperdal (risperidone) gynecomastia lawsuits against Johnson & Johnson and Janssen Pharmaceuticals in 2017, bringing the total to more than 5,500, Forbes reported. According to reports from the Philadelphia Court of Common Pleas,...
By Michelle Llamas 
As Americans continue to file hernia mesh lawsuits, Canadians began their hernia mesh class action claiming they weren’t warned of the implant’s risks. The device at the center of the claims is Ethicon’s Physiomesh Hernia Mesh which Health Canada...
By Michelle Llamas 
A Texas man filed a lawsuit against Bristol-Myers Squibb and AstraZeneca claiming the Type 2 diabetes drug Onglyza (saxagliptin) caused heart failure, according to court documents. According to Wrendell Chester’s complaint for damages filed on Feb. 1, 2017 in the United States... Page 1 of 17
The independent gateway for the orthopaedic community. Connecting professionals and patients since 1999.